Cognition Therapeutics, Inc. (CGTX)
0.8174
-0.02
(-2.42%)
USD |
NASDAQ |
Apr 07, 16:00
0.8599
+0.04
(+5.20%)
After-Hours: 06:21
Cognition Therapeutics Shareholders Equity (Quarterly) : 34.27M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Equillium, Inc. | 28.60M |
| Terns Pharmaceuticals, Inc. | 1.007B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.39M |
| Total Liabilities (Quarterly) | 14.12M |
| Debt to Equity Ratio | 0.0186 |
| Current Ratio | 3.447 |
| Net Debt Paydown Yield | -0.01% |